You are here: Home / Company news
A new pipeline for rare genetic diseases cooperated with Sir Run Run Shaw Hospital is on pre-clinical phage.
Time:2024-06-10

Exclcirc (Suzhou) Biomedical Co., Ltd. is developing a circular RNA based therapy for rare genetic diseases and cooperated with Sir Run Run Shaw Hospital. With Exclcirc's unique circulirization and purification platform, the newly designed protein expressing circRNA molecule will be benifite to certain rare genetic diseases in the future.

Back to the top